From the Food and Drug Administration.

Suppr

超能文献

作者信息

Crawford Lester M

机构信息

Office of the Commissioner, US Food and Drug Administration, Rockville, MD 20857, USA.

出版信息

JAMA. 2002 Aug 14;288(6):688.

PMID:12169049

Abstract

摘要

相似文献

From the Food and Drug Administration.

JAMA. 2002 Aug 14;288(6):688.

FDA approves restricted marketing of Lotronex.

FDA Consum. 2002 Jul-Aug;36(4):4.

Contemporary thoughts on the treatment of irritable bowel syndrome.

Manag Care Interface. 2002 Aug;15(8):19-20, 22.

Alosetron to return to market.

Am J Health Syst Pharm. 2002 Jul 15;59(14):1323-4. doi: 10.1093/ajhp/59.14.1323.

FDA advisory panels recommend Lotronex be put back on market.

BMJ. 2002 May 4;324(7345):1053. doi: 10.1136/bmj.324.7345.1053/a.

Lotronex and the FDA: a fatal erosion of integrity.

Lancet. 2001 May 19;357(9268):1544-5. doi: 10.1016/S0140-6736(00)04776-0.

FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.

Health News. 2002 Oct;8(10):1-2.

National policies for xenotransplantation in the USA.

Xenotransplantation. 2007 Jul;14(4):345-6. doi: 10.1111/j.1399-3089.2007.00396.x.

Return of alosetron.

Expert Opin Drug Saf. 2002 May;1(1):1-4. doi: 10.1517/14740338.1.1.1.

Irritable bowel syndrome. A poorly understood disorder.

FDA Consum. 2001 Jul-Aug;35(4):30-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

From the Food and Drug Administration.

JAMA. 2002 Aug 14;288(6):688.

FDA approves restricted marketing of Lotronex.

FDA Consum. 2002 Jul-Aug;36(4):4.

Contemporary thoughts on the treatment of irritable bowel syndrome.

Manag Care Interface. 2002 Aug;15(8):19-20, 22.

Alosetron to return to market.

Am J Health Syst Pharm. 2002 Jul 15;59(14):1323-4. doi: 10.1093/ajhp/59.14.1323.

FDA advisory panels recommend Lotronex be put back on market.

BMJ. 2002 May 4;324(7345):1053. doi: 10.1136/bmj.324.7345.1053/a.

Lotronex and the FDA: a fatal erosion of integrity.

Lancet. 2001 May 19;357(9268):1544-5. doi: 10.1016/S0140-6736(00)04776-0.

FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.

Health News. 2002 Oct;8(10):1-2.

National policies for xenotransplantation in the USA.

Xenotransplantation. 2007 Jul;14(4):345-6. doi: 10.1111/j.1399-3089.2007.00396.x.

Return of alosetron.

Expert Opin Drug Saf. 2002 May;1(1):1-4. doi: 10.1517/14740338.1.1.1.

Irritable bowel syndrome. A poorly understood disorder.

FDA Consum. 2001 Jul-Aug;35(4):30-6.